Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiotepa-Based Conditioning for Haploidentical HSCT in Aged SAA Patients
NCT07819812Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2027
01
Overview
Open-label, single-arm trial of thiotepa in aplastic anemia, sponsored by Peking University People's Hospital. Primary endpoint: Transplant-Related Mortality at 1 year. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
thiotepa
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT07819812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07819812.